We are live on ! Find out more
RGNX icon

Regenxbio

203 hedge funds and large institutions have $2.16B invested in Regenxbio in 2018 Q3 according to their latest regulatory filings, with 48 funds opening new positions, 92 increasing their positions, 49 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

129% more first-time investments, than exits

New positions opened: 48 | Existing positions closed: 21

88% more repeat investments, than reductions

Existing positions increased: 92 | Existing positions reduced: 49

15% more capital invested

Capital invested by funds: $1.87B → $2.16B (+$289M)

15% more funds holding

Funds holding: 177203 (+26)

0.19% more ownership

Funds ownership: 81.49%81.68% (+0.19%)

17% less call options, than puts

Call options by funds: $10.3M | Put options by funds: $12.4M

20% less funds holding in top 10

Funds holding in top 10: 54 (-1)

Holders
203
Holders Change
+26
Holders Change %
+14.69%
% of All Funds
4.64%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.09%
New
48
Increased
92
Reduced
49
Closed
21
Calls
$10.3M
Puts
$12.4M
Net Calls
-$2.12M
Net Calls Change
-$6.82M
Name Holding Trade Value Shares
Change
Change in
Stake
VOYA Investment Management
26
VOYA Investment Management
Georgia
$20.6M +$5.01M +69,484 +34%
Principal Financial Group
27
Principal Financial Group
Iowa
$18.7M +$2.14M +29,671 +14%
AI
28
ArchPoint Investors
Florida
$16.9M +$1.33M +18,473 +9%
TA
29
Teachers Advisors
New York
$16.8M +$975K +13,537 +6%
Norges Bank
30
Norges Bank
Norway
$16.4M +$15.7M +217,664 New
AQR Capital Management
31
AQR Capital Management
Connecticut
$16M +$2.59M +35,915 +20%
Ameriprise
32
Ameriprise
Minnesota
$15.8M +$1.19M +16,511 +9%
Charles Schwab
33
Charles Schwab
California
$14.1M +$3.05M +42,307 +29%
Prudential Financial
34
Prudential Financial
New Jersey
$11.3M +$311K +4,310 +3%
AG
35
Artal Group
Luxembourg
$11.3M
Macquarie Group
36
Macquarie Group
Australia
$11.3M
Two Sigma Advisers
37
Two Sigma Advisers
New York
$10.1M +$8.91M +123,600 +1,224%
Millennium Management
38
Millennium Management
New York
$9.83M +$8.38M +116,336 +837%
Two Sigma Investments
39
Two Sigma Investments
New York
$9.7M +$9.26M +128,514 New
Dimensional Fund Advisors
40
Dimensional Fund Advisors
Texas
$9.42M +$7.65M +106,198 +572%
TCIM
41
TIAA CREF Investment Management
New York
$9.07M -$6.07M -84,255 -41%
UBS AM
42
UBS AM
Illinois
$8.74M +$7.47M +103,628 +855%
CG
43
Carmignac Gestion
France
$8.4M +$2.4M +33,305 +43%
PC
44
Pier Capital
Connecticut
$7.13M -$1.61M -22,321 -19%
Allianz Asset Management
45
Allianz Asset Management
Germany
$6.85M -$1.35M -18,780 -17%
Citigroup
46
Citigroup
New York
$6.66M -$7.18M -99,629 -53%
UBS Group
47
UBS Group
Switzerland
$5.74M +$2.9M +40,293 +113%
AllianceBernstein
48
AllianceBernstein
Tennessee
$5.69M -$1.14M -15,810 -17%
GH
49
GAM Holding
Switzerland
$5.41M
Legal & General Group
50
Legal & General Group
United Kingdom
$5.28M +$1.19M +16,522 +31%

RGNX Hedge Fund Activity: Q3 2018 in Review

203 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Regenxbio (RGNX) for Q3 2018, worth a combined $2.16B — up 15% from $1.87B a quarter earlier.

Buyers outnumbered sellers: 48 funds opened new RGNX positions and 21 closed out — a net gain of 27 holders — while 92 added to existing stakes and 49 trimmed.

The largest buyer was Vanguard Group, adding an estimated $68.3M. The largest seller was RTW Investments, cutting an estimated $44.7M.

  • 203 institutional investors held Regenxbio (RGNX) as of Q3 2018, up from 177 in Q2 2018.
  • Funds reported $2.16B of Regenxbio stock for Q3 2018, up 15% quarter-over-quarter.
  • 48 funds opened new Regenxbio positions in Q3 2018 and 21 closed out, a net change of +27 holders.
  • The largest Regenxbio buyer in Q3 2018 was Vanguard Group, an estimated $68.3M added.
  • The largest Regenxbio seller in Q3 2018 was RTW Investments, an estimated $44.7M sold.

Based on aggregated 13F filings for Q3 2018.